Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models
- Author
- Yves Depetter, Silke Geurs (UGent) , Rob De Vreese (UGent) , Sophie Goethals, Elien Vandoorn, Alien Laevens, Jonas Steenbrugge (UGent) , Evelyne Meyer (UGent) , Pascal de Tullio, marc bracke, Matthias D'hooghe (UGent) and Olivier De Wever (UGent)
- Organization
- Keywords
- Cancer Research, Oncology
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 1.43 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8600750
- MLA
- Depetter, Yves, et al. “Selective Pharmacological Inhibitors of HDAC6 Reveal Biochemical Activity but Functional Tolerance in Cancer Models.” INTERNATIONAL JOURNAL OF CANCER, vol. 145, no. 3, 2019, pp. 735–47, doi:10.1002/ijc.32169.
- APA
- Depetter, Y., Geurs, S., De Vreese, R., Goethals, S., Vandoorn, E., Laevens, A., … De Wever, O. (2019). Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models. INTERNATIONAL JOURNAL OF CANCER, 145(3), 735–747. https://doi.org/10.1002/ijc.32169
- Chicago author-date
- Depetter, Yves, Silke Geurs, Rob De Vreese, Sophie Goethals, Elien Vandoorn, Alien Laevens, Jonas Steenbrugge, et al. 2019. “Selective Pharmacological Inhibitors of HDAC6 Reveal Biochemical Activity but Functional Tolerance in Cancer Models.” INTERNATIONAL JOURNAL OF CANCER 145 (3): 735–47. https://doi.org/10.1002/ijc.32169.
- Chicago author-date (all authors)
- Depetter, Yves, Silke Geurs, Rob De Vreese, Sophie Goethals, Elien Vandoorn, Alien Laevens, Jonas Steenbrugge, Evelyne Meyer, Pascal de Tullio, marc bracke, Matthias D’hooghe, and Olivier De Wever. 2019. “Selective Pharmacological Inhibitors of HDAC6 Reveal Biochemical Activity but Functional Tolerance in Cancer Models.” INTERNATIONAL JOURNAL OF CANCER 145 (3): 735–747. doi:10.1002/ijc.32169.
- Vancouver
- 1.Depetter Y, Geurs S, De Vreese R, Goethals S, Vandoorn E, Laevens A, et al. Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models. INTERNATIONAL JOURNAL OF CANCER. 2019;145(3):735–47.
- IEEE
- [1]Y. Depetter et al., “Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models,” INTERNATIONAL JOURNAL OF CANCER, vol. 145, no. 3, pp. 735–747, 2019.
@article{8600750,
author = {{Depetter, Yves and Geurs, Silke and De Vreese, Rob and Goethals, Sophie and Vandoorn, Elien and Laevens, Alien and Steenbrugge, Jonas and Meyer, Evelyne and de Tullio, Pascal and bracke, marc and D'hooghe, Matthias and De Wever, Olivier}},
issn = {{0020-7136}},
journal = {{INTERNATIONAL JOURNAL OF CANCER}},
keywords = {{Cancer Research,Oncology}},
language = {{eng}},
number = {{3}},
pages = {{735--747}},
title = {{Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models}},
url = {{http://doi.org/10.1002/ijc.32169}},
volume = {{145}},
year = {{2019}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: